Citadel Advisors’s Enveric Biosciences ENVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,060
| Closed | -$27.9K | – | 6119 |
|
|
2025
Q1 | $27.9K | Buy |
20,060
+5,043
| +34% | +$7.01K | ﹤0.01% | 5526 |
|
|
2024
Q4 | $5.38K | Buy |
15,017
+2,264
| +18% | +$811 | ﹤0.01% | 5757 |
|
|
2024
Q3 | $6.05K | Buy |
+12,753
| New | +$6.05K | ﹤0.01% | 5497 |
|
|
2024
Q2 | – | Sell |
-40,104
| Closed | -$40.1K | – | 6139 |
|
|
2024
Q1 | $40.1K | Buy |
+40,104
| New | +$40.1K | ﹤0.01% | 5374 |
|
|
2023
Q3 | – | Sell |
-13,933
| Closed | -$47K | – | 6027 |
|
|
2023
Q2 | $47K | Buy |
+13,933
| New | +$47K | ﹤0.01% | 5007 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6088 |
|
|
2022
Q2 | – | Sell |
-58,332
| Closed | -$20K | – | 6236 |
|
|
2022
Q1 | $20K | Sell |
58,332
-96,805
| -62% | -$33.2K | ﹤0.01% | 6132 |
|
|
2021
Q4 | $144K | Buy |
155,137
+68,488
| +79% | +$63.6K | ﹤0.01% | 5690 |
|
|
2021
Q3 | $179K | Buy |
86,649
+73,564
| +562% | +$152K | ﹤0.01% | 5502 |
|
|
2021
Q2 | $31K | Buy |
+13,085
| New | +$31K | ﹤0.01% | 6289 |
|
|
2021
Q1 | – | Sell |
-10,199
| Closed | -$43K | – | 6374 |
|
|
2020
Q4 | $43K | Buy |
+10,199
| New | +$43K | ﹤0.01% | 4879 |
|
|
2019
Q4 | – | Sell |
-191,485
| Closed | -$33K | – | 4742 |
|
|
2019
Q3 | $33K | Buy |
+191,485
| New | +$33K | ﹤0.01% | 4431 |
|
|
2019
Q1 | – | Sell |
-11,194
| Closed | -$2K | – | 4641 |
|
|
2018
Q4 | $2K | Buy |
+11,194
| New | +$2K | ﹤0.01% | 4442 |
|